Devonian Health Group Management
Management criteria checks 2/4
Devonian Health Group's CEO is Andre Boulet, appointed in Aug 2022, has a tenure of 2.83 years. total yearly compensation is CA$482.99K, comprised of 89.2% salary and 10.8% bonuses, including company stock and options. directly owns 0.057% of the company’s shares, worth CA$10.96K. The average tenure of the management team and the board of directors is 1.5 years and 4.1 years respectively.
Key information
Andre Boulet
Chief executive officer
CA$483.0k
Total compensation
| CEO salary percentage | 89.23% |
| CEO tenure | 2.8yrs |
| CEO ownership | 0.06% |
| Management average tenure | 1.5yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
Take Care Before Jumping Onto Devonian Health Group Inc. (CVE:GSD) Even Though It's 29% Cheaper
Jun 12
Market Cool On Devonian Health Group Inc.'s (CVE:GSD) Revenues Pushing Shares 28% Lower
Apr 19Why Investors Shouldn't Be Surprised By Devonian Health Group Inc.'s (CVE:GSD) 41% Share Price Surge
Mar 02Investors Appear Satisfied With Devonian Health Group Inc.'s (CVE:GSD) Prospects As Shares Rocket 33%
Dec 01Is Devonian Health Group (CVE:GSD) A Risky Investment?
Mar 20Is Devonian Health Group (CVE:GSD) Using Debt In A Risky Way?
Dec 01Is Devonian Health Group (CVE:GSD) Weighed On By Its Debt Load?
Aug 18Does Devonian Health Group (CVE:GSD) Have A Healthy Balance Sheet?
Apr 24Does Devonian Health Group's (CVE:GSD) CEO Salary Compare Well With Industry Peers?
Mar 02CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jan 31 2025 | n/a | n/a | -CA$127k |
| Oct 31 2024 | n/a | n/a | -CA$1m |
| Jul 31 2024 | CA$483k | CA$431k | -CA$1m |
| Apr 30 2024 | n/a | n/a | -CA$3m |
| Jan 31 2024 | n/a | n/a | -CA$4m |
| Oct 31 2023 | n/a | n/a | -CA$4m |
| Jul 31 2023 | CA$645k | CA$395k | -CA$5m |
| Apr 30 2023 | n/a | n/a | -CA$5m |
| Jan 31 2023 | n/a | n/a | -CA$4m |
| Oct 31 2022 | n/a | n/a | -CA$4m |
| Jul 31 2022 | CA$391k | CA$346k | -CA$3m |
| Apr 30 2022 | n/a | n/a | -CA$4m |
| Jan 31 2022 | n/a | n/a | -CA$4m |
| Oct 31 2021 | n/a | n/a | -CA$3m |
| Jul 31 2021 | CA$245k | CA$200k | -CA$3m |
| Apr 30 2021 | n/a | n/a | -CA$4m |
| Jan 31 2021 | n/a | n/a | -CA$4m |
| Oct 31 2020 | n/a | n/a | -CA$4m |
| Jul 31 2020 | CA$216k | CA$200k | -CA$4m |
| Apr 30 2020 | n/a | n/a | -CA$4m |
| Jan 31 2020 | n/a | n/a | -CA$4m |
| Oct 31 2019 | n/a | n/a | -CA$3m |
| Jul 31 2019 | CA$212k | CA$200k | -CA$3m |
| Apr 30 2019 | n/a | n/a | -CA$3m |
| Jan 31 2019 | n/a | n/a | -CA$3m |
| Oct 31 2018 | n/a | n/a | -CA$3m |
| Jul 31 2018 | CA$244k | CA$200k | -CA$3m |
Compensation vs Market: Andre's total compensation ($USD352.54K) is above average for companies of similar size in the Canadian market ($USD164.88K).
Compensation vs Earnings: Andre's compensation has been consistent with company performance over the past year.
CEO
Andre Boulet (66 yo)
Dr. Andre P. Boulet, Ph D., serves as a Co-Founder of Biomundis (V.C.) and serves as its Partner, Chief Operating Officer and Scientific Affairs officer. Dr. Boulet had been Chief Executive Officer and Pre...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| COO, CEO | 2.8yrs | CA$482.99k | 0.057% CA$ 11.0k | |
| Executive VP of Strategy | 1.5yrs | CA$395.54k | no data | |
| Chief Financial Officer | less than a year | no data | no data |
Experienced Management: GSD's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| COO, CEO | 10.3yrs | CA$482.99k | 0.057% CA$ 11.0k | |
| Executive VP of Strategy | 2.3yrs | CA$395.54k | no data | |
| Director | less than a year | no data | no data | |
| Member of Scientific Advisory Board | 5.9yrs | no data | no data | |
| Independent Director | 2.1yrs | no data | 0.45% CA$ 86.7k | |
| Independent Director | 1.3yrs | no data | no data | |
| Independent Director | 2.1yrs | CA$41.38k | no data | |
| Member of Scientific Advisory Board & Independent Director | 8.1yrs | CA$4.00k | no data | |
| Member of Scientific Advisory Board | 6.2yrs | no data | no data | |
| Member of Scientific Advisory Board | 6.2yrs | no data | no data | |
| Member of Scientific Advisory Board | 6.2yrs | no data | no data | |
| Independent Director | 2.1yrs | no data | no data |
Experienced Board: GSD's board of directors are considered experienced (4.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/19 02:38 |
| End of Day Share Price | 2025/06/17 00:00 |
| Earnings | 2025/01/31 |
| Annual Earnings | 2024/07/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Devonian Health Group Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.